Merrimack Pharmaceuticals (MACK) Stock Highlights

15.13 | +0%

2024-12-21 06:14:59

Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The companys core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.

Statistics

Range Today

15.13 15.13

Volume Today 0

Range 1 Year

11.53 15.89

Volume 1 Year 26.42M

Range 3 Year

3 15.89

Volume 3 Year 90.48M

Range 10 Year

1.49 108.891

Volume 10 Year 497.58M

Highlights

Market Capitalization 223.75M (small)

Floating Shares 9.66M

Current Price 15.13

Price To Earnings -168.33

Price To Book 0.99

Earnings Per Share -0.09

Dividend Yield 100%

Dividend Per Share 15.1

Payout Ratio 0%

Performance

Latest 0%

1 Month +2.44%

3 Months +3%

6 Months +17.74%

1 Year +21.04%

3 Years +137.89%

5 Years +207.68%

10 Years -75.96%

Benchmarks

Market Capitalization

222 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

195 / 368

Free Cashflow

40 / 352

Performance 5 years

38 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.